{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:01:28Z","timestamp":1773270088386,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Programa Institucional de Aux\u00edlio \u00e0 Pesquisa de Doutores Rec\u00e9m-Contratados da PRPq\/Universidade Federal de Minas Gerais"},{"name":"PROBIC\/FAPEMIG"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.pharep.2019.08.001","type":"journal-article","created":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T11:14:03Z","timestamp":1566040443000},"page":"1177-1183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["The phthalimide analogues N-3-hydroxypropylphthalimide and N-carboxymethyl-3-nitrophthalimide exhibit activity in experimental models of inflammatory and neuropathic pain"],"prefix":"10.1007","volume":"71","author":[{"given":"Carla R.A.","family":"Batista","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana M.","family":"Godin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivo S.F.","family":"Melo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanna M.E.","family":"Coura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamires C.","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcela M.G.B.","family":"Dutra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Mercy S.","family":"Brito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wagner G.","family":"Canhestro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo J.","family":"Alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D\u00e9bora P.","family":"Ara\u00fajo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c2ngelo","family":"de F\u00e1tima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renes R.","family":"Machado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e1rcio M.","family":"Coelho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"8","key":"10.1016\/j.pharep.2019.08.001_bib0005","doi-asserted-by":"crossref","first-page":"678","DOI":"10.2174\/138955710791572442","article-title":"Recent advances in the chemistry of phthalimide analogues and their therapeutic potential","volume":"10","author":"Sharma","year":"2010","journal-title":"Mini Rev Med Chem"},{"issue":"3","key":"10.1016\/j.pharep.2019.08.001_bib0010","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1084\/jem.173.3.699","article-title":"Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes","volume":"173","author":"Sampaio","year":"1991","journal-title":"J Exp Med"},{"issue":"50","key":"10.1016\/j.pharep.2019.08.001_bib0015","doi-asserted-by":"crossref","first-page":"E4818","DOI":"10.1073\/pnas.1315875110","article-title":"Pomalidomide is strongly antiangiogenic and teratogenic in relevant animal models","volume":"110","author":"D\u2019Amato","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.pharep.2019.08.001_bib0020","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.det.2010.03.003","article-title":"Innovative uses of thalidomide","volume":"28","author":"Chen","year":"2010","journal-title":"Dermatol Clin"},{"issue":"2","key":"10.1016\/j.pharep.2019.08.001_bib0025","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1517\/14656566.2016.1115016","article-title":"New pharmacotherapy options for multiple myeloma","volume":"17","author":"Mina","year":"2016","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"10.1016\/j.pharep.2019.08.001_bib0030","doi-asserted-by":"crossref","first-page":"380","DOI":"10.4049\/jimmunol.163.1.380","article-title":"Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha","volume":"163","author":"Corral","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.pharep.2019.08.001_bib0035","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1038\/bcj.2013.38","article-title":"Pomalidomide: the new immunomodulatory agent for the treatment of multiple myeloma","volume":"3","author":"Chanan-Khan","year":"2013","journal-title":"Blood Cancer J"},{"issue":"1","key":"10.1016\/j.pharep.2019.08.001_bib0040","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0304-3959(97)00154-1","article-title":"The effect of thalidomide treatment on vascular pathology and hyperalgesia caused by chronic constriction injury of rat nerve","volume":"74","author":"Sommer","year":"1998","journal-title":"Pain"},{"issue":"1\u20132","key":"10.1016\/j.pharep.2019.08.001_bib0045","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0014-2999(99)00918-8","article-title":"Analgesic effect of thalidomide on inflammatory pain","volume":"391","author":"Ribeiro","year":"2000","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"10.1016\/j.pharep.2019.08.001_bib0050","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/sj.bjp.0706775","article-title":"Relevance of tumour necrosis factor-alpha for the inflammatory and nociceptive responses evoked by carrageenan in the mouse paw","volume":"148","author":"Rocha","year":"2006","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.pharep.2019.08.001_bib0055","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1517\/14740338.2011.527331","article-title":"Managing the teratogenic risk of thalidomide and lenalidomide: an industry perspective","volume":"10","author":"Bwire","year":"2011","journal-title":"Expert Opin Drug Saf"},{"issue":"1","key":"10.1016\/j.pharep.2019.08.001_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1520-6866(1997)17:1<1::AID-TCM2>3.0.CO;2-L","article-title":"Interaction of [glutarimide-2-14C]-thalidomide with rat embryonic DNA in vivo","volume":"17","author":"Huang","year":"1997","journal-title":"Teratog Carcinog Mutagen"},{"issue":"9","key":"10.1016\/j.pharep.2019.08.001_bib0065","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1021\/jm0304820","article-title":"Comparative molecular field analysis and comparative molecular similarity indices analysis of thalidomide analogues as angiogenesis inhibitors","volume":"47","author":"Lepper","year":"2004","journal-title":"J Med Chem"},{"key":"10.1016\/j.pharep.2019.08.001_bib0070","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.pbb.2014.04.008","article-title":"Activities of 2-phthalimidethanol and 2-phthalimidethyl nitrate, phthalimide analogs devoid of the glutarimide moiety, in experimental models of inflammatory pain and edema","volume":"122","author":"Godin","year":"2014","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharep.2019.08.001_bib0075","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejphar.2015.02.052","article-title":"Activities of 2-phthalimidethyl nitrate and 2-phthalimidethanol in the models of nociceptive response and edema induced by formaldehyde in mice and preliminary investigation of the underlying mechanisms","volume":"756","author":"Godin","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharep.2019.08.001_bib0080","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.ejmech.2015.04.041","article-title":"Design, synthesis and structure-activity relationship of phthalimides endowed with dual antiproliferative and immunomodulatory activities","volume":"96","author":"Cardoso","year":"2015","journal-title":"Eur J Med Chem"},{"issue":"4","key":"10.1016\/j.pharep.2019.08.001_bib0085","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.pharep.2017.01.033","article-title":"2-Phthalimidethanol and 2-phthalimidethyl nitrate inhibit mechanical allodynia, neutrophil recruitment and cytokine and chemokine production in a murine model of articular inflammation","volume":"69","author":"Godin","year":"2017","journal-title":"Pharmacol Rep"},{"issue":"13","key":"10.1016\/j.pharep.2019.08.001_bib0090","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1016\/j.bmc.2017.04.027","article-title":"Synthesis and biological activity of new phthalimides as potential anti-inflammatory agents","volume":"25","author":"Bach","year":"2017","journal-title":"Bioorg Med Chem"},{"issue":"13","key":"10.1016\/j.pharep.2019.08.001_bib0095","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1517\/14656566.2015.1076794","article-title":"Apremilast for the treatment of psoriasis","volume":"16","author":"Chimenti","year":"2015","journal-title":"Expert Opin Pharmacother"},{"issue":"4","key":"10.1016\/j.pharep.2019.08.001_bib0100","doi-asserted-by":"crossref","first-page":"514","DOI":"10.2340\/00015555-2360","article-title":"Effects of apremilast on pruritus and skin discomfort\/pain correlate with improvements in quality of life in patients with moderate to severe plaque psoriasis","volume":"96","author":"Sobell","year":"2016","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"10.1016\/j.pharep.2019.08.001_bib0105","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/0031-9384(90)90025-Y","article-title":"Thermal biology of the laboratory rat","volume":"47","author":"Gordon","year":"1990","journal-title":"Physiol Behav"},{"issue":"3","key":"10.1016\/j.pharep.2019.08.001_bib0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032799","article-title":"Heat or insulation: behavioral titration of mouse preference for warmth or access to a nest","volume":"7","author":"Gaskill","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.pharep.2019.08.001_bib0115","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0304-3959(83)90201-4","article-title":"Ethical guidelines for investigations of experimental pain in conscious animals","volume":"16","author":"Zimmermann","year":"1983","journal-title":"Pain"},{"issue":"9","key":"10.1016\/j.pharep.2019.08.001_bib0120","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.1021\/ja01153a098","article-title":"The synthesis of substituted penicillins and simpler structural analogs. II. \u03b1-Acylamino-\u03b2-lactam-thiazolidines","volume":"73","author":"Sheehan","year":"1951","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.pharep.2019.08.001_bib0125","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ejphar.2015.10.047","article-title":"Opioid pathways activation mediates the activity of nicorandil in experimental models of nociceptive and inflammatory pain","volume":"768","author":"Dutra","year":"2015","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.pharep.2019.08.001_bib0130","first-page":"304","article-title":"Antinociceptive action of 2-(4-bromobenzoyl)-3-methyl-4,6-dimethoxy benzofuran, a novel xanthoxyline derivative on chemical and thermal models of nociception in mice","volume":"278","author":"Vaz","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.pharep.2019.08.001_bib0135","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3959(88)90209-6","article-title":"A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man","volume":"33","author":"Bennett","year":"1988","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.pharep.2019.08.001_bib0140","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1590\/S0100-879X2004000300018","article-title":"An electronic pressure-meter nociception paw test for mice","volume":"37","author":"Cunha","year":"2004","journal-title":"Braz J Med Biol Res"},{"issue":"2","key":"10.1016\/j.pharep.2019.08.001_bib0145","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0091-3057(88)90372-3","article-title":"Unilateral inflammation of the hindpaw in rats as a model of prolonged noxious stimulation: alterations in behavior and nociceptive thresholds","volume":"31","author":"Stein","year":"1988","journal-title":"Pharmacol Biochem Behav"},{"issue":"8","key":"10.1016\/j.pharep.2019.08.001_bib0150","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/j.bmc.2015.02.029","article-title":"Design, synthesis and biological evaluation of functionalized phthalimides: a new class of antimalarials and inhibitors of falcipain-2, a major hemoglobinase of malaria parasite","volume":"23","author":"Singh","year":"2015","journal-title":"Bioorg Med Chem"},{"issue":"1","key":"10.1016\/j.pharep.2019.08.001_bib0155","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0304-3959(92)90003-T","article-title":"The formalin test: an evaluation of the method","volume":"51","author":"Tjolsen","year":"1992","journal-title":"Pain"},{"issue":"33","key":"10.1016\/j.pharep.2019.08.001_bib0160","doi-asserted-by":"crossref","first-page":"13525","DOI":"10.1073\/pnas.0705924104","article-title":"TRPA1 mediates formalin-induced pain","volume":"104","author":"McNamara","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.pharep.2019.08.001_bib0165","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ejphar.2006.03.008","article-title":"Potent analgesic effects of a putative sodium channel blocker M58373 on formalin-induced and neuropathic pain in rats","volume":"536","author":"Akada","year":"2006","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"10.1016\/j.pharep.2019.08.001_bib0170","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0304-3959(87)90088-1","article-title":"The formalin test in mice: dissociation between inflammatory and non-inflammatory pain","volume":"30","author":"Hunskaar","year":"1987","journal-title":"Pain"},{"issue":"7","key":"10.1016\/j.pharep.2019.08.001_bib0175","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrn1700","article-title":"Role of the immune system in chronic pain","volume":"6","author":"Marchand","year":"2005","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"10.1016\/j.pharep.2019.08.001_bib0180","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1213\/01.ane.0000275190.42912.37","article-title":"Pathophysiology of peripheral neuropathic pain: immune cells and molecules","volume":"105","author":"Thacker","year":"2007","journal-title":"Anesth Analg"},{"issue":"2","key":"10.1016\/j.pharep.2019.08.001_bib0185","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1124\/jpet.103.050781","article-title":"Allodynia and hyperalgesia in adjuvant-induced arthritic rats: time course of progression and efficacy of analgesics","volume":"306","author":"Nagakura","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"issue":"11","key":"10.1016\/j.pharep.2019.08.001_bib0190","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/nm.2234","article-title":"Interactions between the immune and nervous systems in pain","volume":"16","author":"Ren","year":"2010","journal-title":"Nature Med"},{"issue":"1","key":"10.1016\/j.pharep.2019.08.001_bib0195","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.pharmthera.2010.01.002","article-title":"Chemokines, neuronal-glial interactions, and central processing of neuropathic pain","volume":"126","author":"Gao","year":"2010","journal-title":"Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.pharep.2019.08.001_bib0200","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000107711","article-title":"Newer N-phthaloyl GABA derivatives with antiallodynic and antihyperalgesic activities in both sciatic nerve and spinal nerve ligation models of neuropathic pain","volume":"81","author":"Yogeeswari","year":"2008","journal-title":"Pharmacology"},{"issue":"4","key":"10.1016\/j.pharep.2019.08.001_bib0205","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/BF03401909","article-title":"Selection of novel analogs of thalidomide with enhanced tumor necrosis factor alpha inhibitory activity","volume":"2","author":"Corral","year":"1996","journal-title":"Mol Med"},{"issue":"3","key":"10.1016\/j.pharep.2019.08.001_bib0210","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.intimp.2004.10.017","article-title":"LASSBio-468: a new achiral thalidomide analogue which modulates TNF-alpha and NO production and inhibits endotoxic shock and arthritis in an animal model","volume":"5","author":"Alexandre-Moreira","year":"2005","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"10.1016\/j.pharep.2019.08.001_bib0215","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.bmcl.2010.12.031","article-title":"Design, synthesis and biological evaluation of new thalidomide analogues as TNF-alpha and IL-6 production inhibitors","volume":"21","author":"Chaulet","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"10.1016\/j.pharep.2019.08.001_bib0220","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0014-2999(95)00045-M","article-title":"Peripheral opioid modulation of pain and inflammation in the formalin test","volume":"277","author":"Hong","year":"1995","journal-title":"Eur J Pharmacol"},{"issue":"2","key":"10.1016\/j.pharep.2019.08.001_bib0225","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1254\/jphs.94.161","article-title":"Possible involvement of opioidergic and serotonergic mechanisms in antinociceptive effect of paroxetine in acute pain","volume":"94","author":"Duman","year":"2004","journal-title":"J Pharmacol Sci"},{"issue":"3","key":"10.1016\/j.pharep.2019.08.001_bib0230","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1124\/jpet.114.214031","article-title":"Characteristics of TRK-130 (Naltalimide), a novel opioid ligand, as a new therapeutic agent for overactive bladder","volume":"350","author":"Fujimura","year":"2014","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114019303238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114019303238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:38:11Z","timestamp":1752611891000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2019.08.001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S1734114019303238"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2019.08.001","relation":{},"ISSN":["1734-1140"],"issn-type":[{"value":"1734-1140","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The phthalimide analogues N-3-hydroxypropylphthalimide and N-carboxymethyl-3-nitrophthalimide exhibit activity in experimental models of inflammatory and neuropathic pain","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2019.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}